Nutritional Outlook Magazine

  • Home
  • Nutritional Outlook Magazine

Nutritional Outlook Magazine Nutritional Outlook is an award-winning multimedia publishing brand for the dietary supplement, healthy foods, and natural products market. Founded in 1998.

Nutritional Outlook, an MJH Life Sciences brand, provides insights and industry updates critical to manufacturers of dietary supplements, healthy foods, nutritious beverages, and natural products. Nutritional Outlook keeps industry abreast of current market trends, research updates, news, and regulatory developments. Nutritional Outlook goes beyond the 24-hour news cycle and provides in-depth analysis to help industry players navigate the challenges and changes in the near- and long-term. Nutritional Outlook is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels. Also follow us on:
LinkedIn: https://www.linkedin.com/showcase/nutritional-outlook

Twitter: https://twitter.com/nutritionalO

Berberine FAQ: What Formulators and Brands Need to KnowBerberine's rise in the supplement aisle, fueled largely by socia...
07/09/2026

Berberine FAQ: What Formulators and Brands Need to Know

Berberine's rise in the supplement aisle, fueled largely by social media attention to its metabolic benefits, has outpaced the underlying evidence in several respects.

Poor bioavailability has driven new delivery technologies aimed at lowering effective doses, while recent third-party testing found widespread potency shortfalls across the market — a reminder of why verified quality control matters.

This FAQ walks through what the research does and doesn't support, safety considerations, and where the category's quality gaps lie.

➡️ Read the full overview: https://hubs.li/Q04wNcB00

"Fermentation" gets used as a catch-all in ingredient conversations, but the term spans very different processes — each ...
06/09/2026

"Fermentation" gets used as a catch-all in ingredient conversations, but the term spans very different processes — each with its own cost structure, scalability, and ideal use case.

Industry experts also note the sustainability story often associated with fermentation — less land use, reduced agricultural dependency — holds up differently depending on which end of the spectrum an ingredient comes from. And even where fermentation offers a technical advantage, scaling can be gated less by R&D and more by downstream finishing infrastructure.

Understanding the distinctions matters for anyone sourcing or formulating with fermentation-derived ingredients.

➡️ Read the full article: https://hubs.li/Q04wM-q80

🌱 FDA Opens Public Comment Period on Botanical Drug DevelopmentFDA has issued a request for information inviting industr...
05/09/2026

🌱 FDA Opens Public Comment Period on Botanical Drug Development

FDA has issued a request for information inviting industry, researchers, and clinicians to weigh in on how the agency can better support botanical drug development. Comments are due November 3, 2026.

The RFI seeks input on R&D obstacles, quality benchmarks, trial design for multi-constituent mixtures, and the potential role of real-world evidence. It follows an FDA/Reagan-Udall Foundation roundtable that identified key barriers to bringing botanical drugs to market.

Only four botanical products have cleared FDA's prescription drug pathways to date.

FDA and EMA will also hold a joint workshop comparing U.S. and EU regulatory approaches to botanical drugs on September 25 in Amsterdam.

➡️ Read the full article: https://hubs.li/Q04wMR5K0

Why do promising ingredients underperform in human trials? Often it's not the ingredient — it's who's enrolled.New from ...
03/09/2026

Why do promising ingredients underperform in human trials? Often it's not the ingredient — it's who's enrolled.

New from Jayesh Chaudhary and Dr. Sachin Dighe (Vedic Lifesciences): broad eligibility criteria like "overweight" pool together biologically distinct subgroups, potentially diluting treatment signals. The piece makes the case for phenotype-based recruitment, matching participant biology to mechanism, and argues that recruitment intelligence, not just sample size, may be the next differentiator in nutraceutical clinical evidence.

➡️ Read it here: https://hubs.li/Q04wyXW60

Big move in the vitamins and supplements space: Yellow Wood Partners has agreed to buy Nestlé's Nature's Bounty, Nuun, O...
02/09/2026

Big move in the vitamins and supplements space: Yellow Wood Partners has agreed to buy Nestlé's Nature's Bounty, Nuun, Osteo Bi-Flex, and Gard brands for $1 billion, in a deal expected to close in the first half of 2027.

Nature's Bounty is used in more than 1 in 5 U.S. households, so this is a significant shift in ownership for one of the category's biggest names. We break down what's changing hands, what Nestlé is holding onto, and what it signals about the broader supplements M&A market.

Read more: https://hubs.li/Q04wfzYh0

31/08/2026

Future Nutra Foundation's Innovation Summit is coming September 9–11 in Lake Conroe, TX.

In an interview with Nutritional Outlook, Future Nutra Foundation's founder Joey Savage and partnerships director Ben Kane break down what sets the event apart: no scheduled meetings, a slower pace built for discovery, and 48 educational talks running alongside the trade show floor. Speakers include Ghost founder Dan Lourenco, NPA's Dan Fabricant, Iovate CEO Raza Bashir, and SPINS' Scott Dicker on industry anti-trends.

🎥 Watch the full interview for more on Future Nutra's third-party testing work and what's on the Summit agenda: https://hubs.li/Q04v_TqC0

📣 Nutritional Outlook® and TruShield™ Certified are teaming up for a new educational track at "The Outlook on Active Nut...
28/08/2026

📣 Nutritional Outlook® and TruShield™ Certified are teaming up for a new educational track at "The Outlook on Active Nutrition," taking place September 24, 2026 in East Windsor, NJ.

The two sessions will explore certification and quality management in sports nutrition — from adulteration risks and detection protocols to a real-world case study with CON-CRĒT Creatine HCI. Speakers include Marc Lobliner (Ketone Labs/goBHB), Doug Grant (Optimal Health Systems), Karen Hecht, PhD (AstaReal), Lori Bestervelt (TruShield™ Certified), and Mark Faulkner (Vireo Systems).

➡️ Learn more and register: https://hubs.li/Q04vLHKq0

📬 Our July/August issue is now live!➡️ Read the full issue here: https://hubs.li/Q04vnPqC0✔️ Dive deeper into trends in ...
26/08/2026

📬 Our July/August issue is now live!
➡️ Read the full issue here: https://hubs.li/Q04vnPqC0

✔️ Dive deeper into trends in children's immune health nutraceuticals
✔️ Managing perceptions on "ultraprocessed" foods - Standardizing food date labels - Formulating bone health products for a broader audience - Inside the fermentation spectrum - The benefits of upcycled nutraceuticals - What's new in sweeteners

➕ Plus, view the 29th annual supplier profile directory!

✨ Thank you to everyone who shared their insights in these articles: Metagenics - GC Rieber VivoMega - Cargill - IFIC - International Food Information Council - Nutraland USA, Inc. - Gnosis by Lesaffre

After 16 years at the helm, Scott Melville is stepping down as president and CEO of the Consumer Healthcare Products Ass...
24/08/2026

After 16 years at the helm, Scott Melville is stepping down as president and CEO of the Consumer Healthcare Products Association, the trade group representing OTC medicine, dietary supplement, and medical device manufacturers.

Under his leadership, CHPA broadened from an OTC-focused association into what it now calls the voice of the self-care industry, and the group points to the 2020 CARES Act overhaul of OTC drug regulation and the restoration of HSA/FSA eligibility for OTC products among its major achievements.

A successor hasn't been named yet. Here's what we know so far about the transition: https://hubs.li/Q04v3GFc0

A new peer-reviewed study in Toxicology Reports adds to the safety data set behind TruCBN, FloraWorks' high-purity canna...
23/08/2026

A new peer-reviewed study in Toxicology Reports adds to the safety data set behind TruCBN, FloraWorks' high-purity cannabinol (CBN) isolate designed as a sleep aid. FloraWorks also announced it has completed an internal GRAS assessment for TruCBN, now under independent expert review, as the ingredient's data set is positioned to support a pending FDA New Dietary Ingredient Notification.

➡️ Read the study details: https://hubs.li/Q04tWqLX0

Address


Alerts

Be the first to know and let us send you an email when Nutritional Outlook Magazine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Nutritional Outlook Magazine:

Shortcuts

  • Want your business to be the top-listed Media Company?

Share